Nexus Drugs Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2001.
2001 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Nexus Drugs Private Limited

Nexus Drugs Private Limited, a active private limited company, was established on 02 February 2001 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24243TG2001PTC036160. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

It upholds a compliant status. Its leadership includes Mallikarjun Koyilakonda (Director), Suresh Kilaru (Director). Past directors included Nannuri Lakshmi Prasanna, Pera Reddy Devarapally, Srinivasa Reddy Devireddy. It holds ₹1.11 Cr open charges and ₹1.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 34, Flat No 201, Magistic Chambers East Srinivas Nagar, S R Nagar, Hyderabad, Telangana, 500038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24243TG2001PTC036160

  • Registration Number

    036160

  • Incorporation Date

    02 February 2001

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 25 Year, 19 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.11 Cr
  • Satisfied Charges ₹ 1.00 Cr
  • Revenue Growth **** -41.60%
  • Profit Growth **** 23.09%
  • Ebitda **** -9.18%
  • Net Worth 0.61%
  • Total Assets -11.68%
Company report

Nexus Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nexus Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nexus Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Mallikarjun Koyilakonda Director 20 Oct 2023 Current
Suresh Kilaru Director 13 Aug 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Dec 2012 Past
Pramod Abcsdd Director 02 Dec 2020 Past
Pramod Abcsdd Director 02 Dec 2020 Past
Pramod Abcsdd Director 20 Feb 2015 Past
Pramod Abcsdd Director 06 Feb 2025 Past
Pramod Abcsdd Director 30 May 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nexus Drugs.

Nexus Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.6% decrease. The company also saw a substantial improvement in profitability, with a 23.09% increase in profit. The company's net worth moved up by a moderate rise of 0.61%.

Nexus Drugs revenue growth over time
Nexus Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -41.60%
*******
*******
*******
*******
Revenue from Operations
*******
 -41.61%
*******
*******
*******
*******
Total Assets
*******
 -11.68%
*******
*******
*******
*******
Profit or Loss
*******
 23.09%
*******
*******
*******
*******
Net Worth
*******
 0.61%
*******
*******
*******
*******
EBITDA
*******
 -9.18%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nexus Drugs?

Unlock access to Nexus Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹11,125,000.00

Satisfied Charges

₹10,000,000.00

Charges Breakdown by Lending Institutions
  • Andhra Bank : 1.11 Cr
Latest Charge Details
Date Lender Amount Status
14 Feb 2012 Andhra Bank ₹1.11 Cr Open
22 Dec 2009 Andhra Bank ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nexus Drugs?

Unlock and access historical data on people associated with Nexus Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nexus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nexus Drugs
Recent Activity within the Organization
  • Charges

    A charge registered on 22 Dec 2009 via Charge ID 10200926 with Andhra Bank was fully satisfied on 02 Dec 2024. was recorded as a recent event.

  • Annual General Meeting

    Progress on Nexus Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Nexus Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Mallikarjun Koyilakonda was appointed as a Director was appointed as a Director on 20 Oct 2023 & has been associated with this company since 2 years 4 months . was documented.

  • Director Appointment

    The activity Suresh Kilaru was appointed as a Director was appointed as a Director on 13 Aug 2020 & has been associated with this company since 5 years 6 months . was completed.

  • Charges

    A charge with Andhra Bank of Rs. 1.11 Cr registered on 14 Feb 2012 with Charge ID 10341791 was modified on 13 Dec 2013. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nexus Drugs Private Limited?

The CIN of Nexus Drugs Private Limited is U24243TG2001PTC036160.

Where is Nexus Drugs Private Limited headquartered?

Nexus Drugs Private Limited is headquartered at Plot No 34, Flat No 201, Magistic Chambers East Srinivas Nagar, S R Nagar, Hyderabad, Telangana, 500038.

When was Nexus Drugs Private Limited incorporated?

Nexus Drugs Private Limited was incorporated on 02 February 2001.

Who are the current directors of Nexus Drugs Private Limited?

The current directors of Nexus Drugs Private Limited are

What is the primary industry of Nexus Drugs Private Limited?

The primary industry of Nexus Drugs Private Limited is Manufacturing.

Is Nexus Drugs Private Limited a listed company?

Nexus Drugs Private Limited is unlisted.

What is the capital structure of Nexus Drugs Private Limited?

The authorized capital of Nexus Drugs Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Nexus Drugs Private Limited?

The compliance status of Nexus Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available